Leucovorin Calcium Injection Market

This medication is used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). It may also be used with a certain cancer drug (5-fluorouracil) to treat patients with colon cancer.

Leucovorin Calcium Injection Market contains market size and forecasts of Leucovorin Calcium Injection in global, including the following market information:

Global Leucovorin Calcium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Leucovorin Calcium Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Leucovorin Calcium Injection companies in 2021 (%)

The global Leucovorin Calcium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50mg/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leucovorin Calcium Injection include Hikma, Sagent, Mylan, Fresenius Kabi, Teva, Get Well Pharmaceutical, RMPL Pharma and BluePoint Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Leucovorin Calcium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leucovorin Calcium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Leucovorin Calcium Injection Market Segment Percentages, by Type, 2021 (%)

• 50mg/vial
• 100mg/vial
• 200mg/vial
• 350mg/vial

Global Leucovorin Calcium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Leucovorin Calcium Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Leucovorin Calcium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Leucovorin Calcium Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Leucovorin Calcium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Leucovorin Calcium Injection revenues share in global market, 2021 (%)
• Key companies Leucovorin Calcium Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Leucovorin Calcium Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hikma
• Sagent
• Mylan
• Fresenius Kabi
• Teva
• Get Well Pharmaceutical
• RMPL Pharma
• BluePoint Laboratories